Sabby Management’s PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) PVCT.WS Stock Holding History

Sabby Management’s Portfolio PVCT.WS Stock Details PVCT.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-749,337	Closed	-$164K	–	430
2015 Q2	$164K	Buy	+749,337	New	+$156K	0.01%	303

Other funds holding PVCT.WS

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management's PVCT.WS Position: Q3 2015 in Review

Sabby Management sold out of PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) (PVCT.WS) in Q3 2015, closing a stake of 749,337 shares — an estimated $164K sold.

Sabby Management first reported a position in PVCT.WS in Q2 2015 and held it in 1 quarter. The position peaked at $164K in Q2 2015. 2 funds tracked by Wall St. Rank hold PVCT.WS as of Q3 2015.

Sabby Management reported no remaining PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) position as of Q3 2015 after selling out during the quarter.
Sabby Management sold 749,337 PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) shares in Q3 2015, an estimated $164K.
Sabby Management first reported a position in PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) in Q2 2015 and held it in 1 quarter.
Sabby Management's PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) position peaked at $164K in Q2 2015.
2 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS INC WTS (DE) as of Q3 2015.

Based on Sabby Management's 13F filing for Q3 2015, filed 16 Nov 2015.